INT310259

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.08
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 4.06
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

ST11 (Homo sapiens)
Pain Link Frequency Relevance Heat
imagery 14 5.00 Very Low Very Low Very Low
palliative 2 5.00 Very Low Very Low Very Low
Perioperative pain 2 5.00 Very Low Very Low Very Low
Pain 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Cancer 116 100.00 Very High Very High Very High
Malignant Neoplastic Disease 6 99.80 Very High Very High Very High
Syndrome 2 99.42 Very High Very High Very High
Insulinoma 2 98.40 Very High Very High Very High
Pancreatic Cancer 84 97.08 Very High Very High Very High
Disease 32 85.28 High High
Metastasis 8 79.68 Quite High
Thrombocytopenia 46 50.00 Quite Low
Thrombosis 6 42.88 Quite Low
Pressure And Volume Under Development 8 39.76 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
PETs have been studied much less frequently than PDAC primarily due to their low prevalence; only about 2,500 new PETs are diagnosed annually in the United States.10–12 PETs are categorized as functional or nonfunctional depending on whether the secreted peptide is biologically active and produces a clinical syndrome; about 50% of nonfunctional PETs secrete peptides that are clinically silent.13 Insulinomas are the most common type of PET, and a majority are benign.14 In contrast, approximately 60% of non-insulin-secreting PETs are malignant.11,15 Due to their less aggressive clinical behavior than PDAC and resistance to most current chemotherapeutic agents, PETs are treated aggressively with resectional therapy.
Localization (secrete) of PETs associated with malignant neoplastic disease, syndrome, cancer, pancreatic cancer and insulinoma
1) Confidence 0.08 Published 2010 Journal J Gastrointest Surg Section Body Doc Link PMC2872015 Disease Relevance 2.02 Pain Relevance 0
PETs have been studied much less frequently than PDAC primarily due to their low prevalence; only about 2,500 new PETs are diagnosed annually in the United States.10–12 PETs are categorized as functional or nonfunctional depending on whether the secreted peptide is biologically active and produces a clinical syndrome; about 50% of nonfunctional PETs secrete peptides that are clinically silent.13 Insulinomas are the most common type of PET, and a majority are benign.14 In contrast, approximately 60% of non-insulin-secreting PETs are malignant.11,15 Due to their less aggressive clinical behavior than PDAC and resistance to most current chemotherapeutic agents, PETs are treated aggressively with resectional therapy.
Localization (secreting) of PETs associated with malignant neoplastic disease, syndrome, cancer, pancreatic cancer and insulinoma
2) Confidence 0.08 Published 2010 Journal J Gastrointest Surg Section Body Doc Link PMC2872015 Disease Relevance 2.04 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox